jCyte Announces Appointment of Adrian Morris as Chief Development Officer

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--jCyte, Inc., a private biotechnology company dedicated to improving the lives of patients with retinal degenerative diseases, announced the continued expansion of the company’s executive management team with the appointment of Adrian Morris as Chief Development Officer. Mr. Morris brings to jCyte over three decades of pharmaceutical industry experience in global leadership roles in R&D, commercial strategy, marketing, and business development, includi